Charles H. Bronson Promotion boosts Florida produce sales by $254M
Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing...
Transcript of Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing...
![Page 1: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/1.jpg)
DTL Partner Advisory Committee &
Topsector Life Sciences and Health Health~Holland
Pro~Motion & In~Motion
Prof. dr. Nico L.U. van Meeteren Executive Director
www.health-holland.com
@HealthHolland
![Page 2: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/2.jpg)
Life Sciences and health Success and change …
2005 Benedictus XVI
Franciscus 2013
![Page 3: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/3.jpg)
Alignment “If ‘I’ is replaced by ‘we’,
even illness turns into wellness”
Strategy building Pro~motion 2016-2019 … In~Motion 2016-2017 …
![Page 4: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/4.jpg)
Health~Holland Ambitions
![Page 5: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/5.jpg)
Programmatic Pillars
![Page 6: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/6.jpg)
Alignement Disciplines, experts and institutions …
![Page 7: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/7.jpg)
Alignment Scenario’s …
![Page 8: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/8.jpg)
Alignement Cross-‘inners’ and cross-overs …
• Public Private Partnership: • Ñational:
• Inner: • AMR, CARDIO, Onco XL, etc.
• Over: • Agrofood, Chemics, CLICK NL, Energy, ICT, Logistics • Building blocks of life and IMDI • European Open Science Cloud
• International: • China, East-Africa, USA
• Communication • News-updates, Portal, Twitter, etc.
• Strategic Partnership • Interdepartemental (EA, Health, SA, etc.)
![Page 9: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/9.jpg)
Programmatic Pillars
![Page 10: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/10.jpg)
Running
• Enabling Technologies Call • ZonMw, LSH, ALW
• Data-Hub • Diverse set of publuc and private (LSH) partners
• FAIR Data Backbone • DTL, ICT, LSH, Min. Health and EA, etc.
![Page 11: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/11.jpg)
Frontrunner
![Page 12: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/12.jpg)
Continuum of participation Reform of acute care (waiting list … empowerment period)
- 1959 -
![Page 13: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/13.jpg)
Strategy building Pro~motion 2016-2019 … In~Motion 2016-2017 …
![Page 14: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/14.jpg)
Topsector Policies and progress …
![Page 15: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/15.jpg)
LSH To do 2015-2016-2017 • Sector:
- Strategische en thematische Alignment - PPPs
– Onco XL, CARDIO, Bouwstenen van Leven, AMR, etc. - Financieringsscenario’s (Health impact bonds)
– TKI – Involveren Charity fondsen/Social Investors/Family funds, Pensioenfondsen,
Zorgverzekeraars, Overheden (P → PP), etc. - Internationaal
– In- en export LSH Portfolio (EU en Push op prio’s [USA, China, Oost Afrika] en Pull) - Communicatie
– Portal, news-updates, etc.
• Haags: - Interdepartementale alignment (o.a. EZ-VWS: Health Deals)
![Page 16: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/16.jpg)
Building PPPs
• H~H PPPs: • Services, MedTech, (Bio)Pharma
• Per pillar • Between pillars (cross-‘inners’) • Between sectors (cross-overs)
• Agro-Food, Chemical, CLICKNL, HTSM. Logistics • Enabling technology ICT: COMMIT2DATA
• From Start up PPPs to Flagship PPPs
![Page 17: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/17.jpg)
PPPs AMR …
• Opdracht: – VWS (i.o.m. LSH)
• Uitvoerder: – Innotact (Projectleider: Maarten van Dongen; [email protected])
• Proces en deliverable: – Contourenplan o.b.v. consultaties (oplevering 1 december) · Speerpunten en contouren van programma · Voorstel Governance en betrokken stakeholders
– Businessplan
• Participatie LSH: – Colja Laane (vanaf 1-11-’15 Nico van Meeteren)
![Page 18: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/18.jpg)
![Page 19: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/19.jpg)
![Page 20: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/20.jpg)
TKI LUMC …
• TKI (k€) · Grondslag aangeleverd: Inzet-aanvragen toegekend:
- 2013: 0 118 - 2014: 0 0 - 2015: 0 246
- Vb: Marieke Bax: Molecular diagnostics in patients with Rheumatoid Arthritis – PPP 2015: 243 + 47
• UMCX - 2014: 8.500 2.00
![Page 21: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/21.jpg)
IC 2016-2017 Zie: www.health-holland.com
• Beheren
• Beïnvloeden
• Verrijken
![Page 22: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/22.jpg)
![Page 23: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/23.jpg)
![Page 24: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/24.jpg)
To do IMDI – LSH …
• To do - Samenwerking
- CoRs – Cross overs · HTSM
- Financiering – TKI · Proces en ‘targets’
– MKB regelingen · MIT · Netwerkbijeenkomsten
- Communicatie - Positionering en profilering
![Page 25: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/25.jpg)
Systems development Rural and Urban Living Labs …
![Page 26: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/26.jpg)
Health~Holland, In~Motion Dutch Topsector Life Science and Health
http://www.health-holland.com/portal
![Page 27: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/27.jpg)
Success Biotech Partner Date Type Amount
ProFibrix Medicines Com. June 2013 M&A $90M upfront, $140M milestones
uniQure n.a. Jan 2014 IPO (Nasdaq) $92M
ArgenX n.a. Jul 2014 IPO (Euronext) $55M
Sapiens Medtronic Aug 2014 M&A $200M
Prosensa BioMarin Nov 2014 M&A $680M upfront, $160M milestones
ProQr n.a Sept 2014 IPO (Nasdaq) $97.5M
T-cell Factory Kite Mar 2015 M&A $21M
uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets
AM-Pharma Pfizer May 2015 M&A $87.5M upfront, $512.5M milestones
Galapagos n.a. May 2015 PO (Nasdaq) $316,7M
Kiadis n.a. Jul 2015 IPO (Euronext) $37M
Merus n.a. Aug 2015 Series C financing $80.5M
Dezima Amgen Sept 2015 M&A $300M upfront, $1.25B milestones
![Page 28: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/28.jpg)
Success
![Page 29: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/29.jpg)
Success
![Page 30: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/30.jpg)
H~H claim
![Page 31: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/31.jpg)
Strategy building
![Page 32: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/32.jpg)
• Limitations • Safety • Innovative alternatives • Smart use of data • Time for change
Better off With … cooperations …
• Breakthrough policy agreements • Health Deals
• Public Private Funding scenario’s • Health Impact Bonds
![Page 33: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/33.jpg)
Future Think inside … continuate success …
“If ‘I’ is replaced by ‘we’, even illness turns into wellness”
![Page 34: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/34.jpg)
Functioneren
![Page 35: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/35.jpg)
Functioneren Life Span …
Func
tioni
ng
Time years of age
Major Life
Event
![Page 36: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/36.jpg)
Functioneren (H)Orde …
![Page 37: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/37.jpg)
Functioneren In health care … 0,0003% …
700.800 (80 x 8760)
200 (80 x 2,5)
![Page 38: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/38.jpg)
How
![Page 39: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/39.jpg)
Change Multi-facits strategie …
![Page 40: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/40.jpg)
PPP Multipurpose professional …
![Page 41: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/41.jpg)
Functioneren in health care Beter besef van en verbod op reductie van essenties …
![Page 42: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/42.jpg)
Self
Jameson and Longo, 2015; Collins and Varmus, 2015
€↑
![Page 43: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/43.jpg)
572
794 839
863 872 870 898
500
550
600
650
700
750
800
850
900
950
1000
2006 2007 2008 2009 2012 2013 2014
Continuum of success Reform …!
Paris, 2015
![Page 44: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/44.jpg)
Irish – Dutch Exchange Programme Proposedi*neraryofexchangeprogramme• Monday22ndFebruary–Wednesday24thFebruary2016
• Monday22ndFebruary
DepartDublin13:25ArriveAmsterdam16:00Recep<onforIrishdelega<on• Tuesday23rdFebruary
VisitMaastrictUniversityHospital,RegionallivingLabs,Testbeds• Wednesday24thFebruary
VisitPhillips,examplesofsuccessfulPublicPrivatePartnerships(PPP’s),briefingwithNicovanMeeterenDepartAmsterdam20:30ArriveDublin21:10
![Page 45: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/45.jpg)
Irish – Dutch Exchange Programme
• Visiting Delegation Provide profiles of delegation members for receiving parties Responsible for own overseas travel arrangements
• Receiving party Arranges collective meetings and fine-tunes programme Responsible for local transport When necessary will arrange or advise on lunches, dinners and hotel reservations.
![Page 46: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/46.jpg)
DICA
• http://www.clinicalaudit.nl/jaarrapportage/2014/algemeen.html
![Page 47: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/47.jpg)
(Kennis) en Innovatiecontract 2016-2017
Health~Holland (Topsector Life Sciences and Health)
www.health-holland.com
![Page 48: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/48.jpg)
Van KIA naar (K)IC
• Kennis en Innovatieagenda 2016-2019
• Juni-augustus: Overleg stakeholders en partners LSH • Min. EZ, OCW, VWS; NFU; NRPO;
Regio’s; SGF; TNO; ZonMw-NOW, etc. • Augustus-september: IC drafts, checks en input TT, RG • 8 september: IC prefinal draft naar EZ t.b.v. Generiek IC • September: IC finaliseren
• Journalistieke bewerking • Makeup en lay-out • Correcties en aanvullingen
PDP, ZonMw-NWO, NWA, etc. • 5 oktober: Ondertekening Generiek IC bij Deltares • 6 oktober: IC H~H/LSH op website • Oktober: KIA-IC glossy summary
• (Kennis en) Innovatiecontract 2016-2017
![Page 49: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/49.jpg)
Van KIA naar (K)IC
• (Kennis en) Innovatiecontract 2016-2017
• Oplegger
• Tabellen Indicatieve inzet 2016 en 2017
• IC-tekst:
• Hoofdlijnen en discussiepunten
• Detailcommentaar naar Nico [email protected]
• Proces • dd. …
![Page 50: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/50.jpg)
To do • TKI succes 2014, 2015, 2016
• Charity fondsen/Social Investors/Family funds: - Social Impact Finance BV:
- Samuel Oudkerk - Kabinetsopdracht “Divident naar maatschappelijke doelen”
- Steven van Eijck, Guus Kramer en Paul Baan - Vermogensfondsen
- Rien van Gent
• Pensioenfondsen:
• Zorgverzekeraars:
![Page 51: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/51.jpg)
Praktijkonderzoek HBO • Agenda Praktijkgericht Onderzoek Health
- Stuurgroep: – Edvard Beem, ZonMw – Geri Bonhof (Vz), RG LSH – Marieke Schuurmans, Chief Nursing Officer – Richard Slotman, NRPO
- Werkgroep – Karin Alfenaar (Secr) + … [email protected]
• Positieve dynamiek; kwaliteit, focus en massa; inhoudelijk gereed • Werksessie 7 oktober
- Bestuur, Directies, CoEs, Lectoraten - Agenda: gezamenlijke programmering, regie en werkafspraken - HCA: regie
– To do: rapportage LSH TKI-pilot Hanzehogeschool
• Publicatie Agenda (oktober) en presentatie RG (8 december)
![Page 52: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/52.jpg)
Continuation of success
![Page 53: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/53.jpg)
Change
![Page 54: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/54.jpg)
For the worse or the better
![Page 55: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/55.jpg)
Habemus
2005
2013
![Page 56: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/56.jpg)
School
![Page 57: Pro~Motion In~Motion€¦ · T-cell Factory Kite Mar 2015 M&A $21M uniQure BMS April 2015 Licensing $50m upfront, $50 near term, $254M milestones plus $217M for other targets AM-Pharma](https://reader034.fdocuments.us/reader034/viewer/2022051917/6008e5f3e8381277360062a3/html5/thumbnails/57.jpg)